OncoBriefs - Oncology Research News

December 29, 2025

From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma

From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma

You're standing in line at the pharmacy, watching the person ahead of you argue about whether their insurance covers a slightly different brand of antacid, and meanwhile - in hospitals and research labs across the world - scientists are casually rewriting the entire playbook for treating one of the...

December 28, 2025

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib

Somewhere inside about 1-2% of non-small cell lung cancers, two genes that absolutely should not be talking to each other are shaking hands - and that handshake is telling cells to grow like they've lost all sense of personal boundaries. The gene in question is RET, short for "rearranged during...

December 28, 2025

First-line zolbetuximab plus mFOLFOX6 and...

First-line zolbetuximab plus mFOLFOX6 and...

Stomach cancer has a protein on its surface that was basically hiding in plain sight for decades - and now three drugs are ganging up on it at once, with results that just dropped in Nature Medicine.

December 27, 2025

Estrogen Patches for Prostate Cancer? Yep, You Read That Right.

Estrogen Patches for Prostate Cancer? Yep, You Read That Right.

Somewhere in a parallel timeline, a scientist is pitching this idea at a conference: "So, we're going to treat prostate cancer - the most male of male cancers - with estrogen patches. The ones you stick on your skin." The room goes quiet. Someone nervously adjusts their tie.

December 27, 2025

Eye Drops Made from Pig Semen: A Revolutionary Cancer Treatment?

Eye Drops Made from Pig Semen: A Revolutionary Cancer Treatment?

Imagine you're at a pharmacy, and the pharmacist hands you a bottle labeled "Pig Semen Eye Drops." Now, before you run for the hills, let's dive into why this might just be the future of cancer treatment. Yes, you heard it right. Scientists are exploring the use of eye drops made from pig semen to...

December 26, 2025

Cultivating the Microbiome to Enhance Cancer Immunotherapy

Cultivating the Microbiome to Enhance Cancer Immunotherapy

Gardening and cancer treatment have about as much in common as a sourdough starter and a pharmaceutical lab - which is to say, surprisingly, almost everything. Both depend on cultivating the right living organisms, in the right conditions, and hoping the whole ecosystem cooperates. Except in one...

December 26, 2025

Dear ctDNA, We See You Now

Dear ctDNA, We See You Now

Hey there, you sneaky little DNA fragment. Yes, you - the circulating tumor DNA floating around in someone's bloodstream right now, thinking you're invisible. You've been slipping past detection for years, hiding in a sea of normal cell-free DNA like a spy in a crowded marketplace. But scientists...

December 25, 2025

Colon Cancer's Spell-Check System is Broken, and That's Actually Good News

Colon Cancer's Spell-Check System is Broken, and That's Actually Good News

Buried inside every cell in your body is a tiny proofreading crew. Their job? Catching typos when your DNA copies itself. The system is called mismatch repair, and when it works, it quietly fixes errors millions of times a day without you ever knowing. But in about 10-15% of colon cancers, the...

December 25, 2025

December 24, 2025

Chewing Tobacco and Breast Cancer: The Link Nobody Was Talking About

Chewing Tobacco and Breast Cancer: The Link Nobody Was Talking About

Breast cancer has a long list of known enemies: genetics, alcohol, obesity, hormone therapy. Tobacco? That one usually gets filed under "lung cancer's problem." But a large new study out of India just crashed that tidy little narrative, and the uninvited guest at the table is chewing tobacco.

December 24, 2025

Coffee, Colonoscopies, and... Bakeoffs? How Scientists Are Racing to Find Pancreatic Cancer Sooner

Coffee, Colonoscopies, and... Bakeoffs? How Scientists Are Racing to Find Pancreatic Cancer Sooner

Cooking competitions, spelling bees, hot dog eating contests - all perfectly normal things to hold a bakeoff for. But biomarkers? Leave it to the Pancreatic Cancer Detection Consortium to turn the search for early cancer detection into a legitimate throwdown.

December 23, 2025

Cells Have Been Keeping Diaries, and Scientists Just Cracked the Lock

Cells Have Been Keeping Diaries, and Scientists Just Cracked the Lock

Every cell in your body has a story. It's born, it reads its genetic instructions, it responds to threats, it makes choices that determine whether it lives, dies, or - in the worst-case scenario - goes rogue. The problem? Cells don't leave a paper trail. By the time you look at a cell's gene...

December 22, 2025

Catch That Sneaky Cancer Early—The Lung Screening Revolution

Catch That Sneaky Cancer Early—The Lung Screening Revolution

Imagine your body is hosting a wild party, and some uninvited guests—it turns out, they're cancer cells—are causing havoc. What if you could spot these troublemakers before they get too rowdy? That's where lung cancer screening campaigns come in, and they're throwing quite the shindig in the world...

December 22, 2025

Cell-Cycle Targeted Cancer Therapy: CDK4 Inhibitors Step Into the Spotlight

Cell-Cycle Targeted Cancer Therapy: CDK4 Inhibitors Step Into the Spotlight

Meet CDK4/6 - a pair of molecular enforcers that tell your cells when it's time to divide. In healthy tissue, they're obedient middle managers, only green-lighting cell division when they get the right signals. But in cancer, they've gone full rogue employee: ignoring every memo from headquarters,...

December 21, 2025

Cancer Vaccines Are Back, and They Brought mRNA Technology From the Pandemic

Cancer Vaccines Are Back, and They Brought mRNA Technology From the Pandemic

Cancer vaccines have been the "next big thing" for about three decades. Every few years, the hype cycle spins up, a few high-profile trials disappoint, and the field quietly goes back to the lab. But something changed during COVID-19. The mRNA platform that Moderna and BioNTech used to develop...

December 21, 2025

Cancer's Worst Nightmare Just Got an Upgrade:...

Cancer's Worst Nightmare Just Got an Upgrade:...

Your body's immune system is already pretty good at spotting troublemakers. But cancer cells? They're the con artists of biology - wearing disguises, forging IDs, and generally making themselves very hard to catch. Traditional chemotherapy's solution has been to carpet-bomb the whole neighborhood...

December 20, 2025

CRISPR Forgot Its Scissors and Became a Cancer Detector Instead

CRISPR Forgot Its Scissors and Became a Cancer Detector Instead

Most people know CRISPR as the gene-editing tool that lets scientists cut DNA with surgical precision. What fewer people realize is that the same molecular machinery can be repurposed into an extraordinarily sensitive diagnostic platform. Instead of editing genes, CRISPR-based diagnostics detect...

December 20, 2025

Cancer Cells Eat Sugar Like They Are Getting Paid For It, and That Might Be Their Weakness

Cancer Cells Eat Sugar Like They Are Getting Paid For It, and That Might Be Their Weakness

In 1924, Otto Warburg noticed something strange: cancer cells consume enormous amounts of glucose and ferment it into lactate even when plenty of oxygen is available for normal respiration. This was weird. Aerobic glycolysis is wildly inefficient - you get 2 ATP per glucose molecule instead of the...

December 19, 2025

CAR-T Cells: Absolute Legends in Blood Cancer, Total Tourists in Solid Tumors

CAR-T Cells: Absolute Legends in Blood Cancer, Total Tourists in Solid Tumors

CAR-T cell therapy is one of the most impressive things humans have ever built. You take a patient's own T cells, genetically engineer them to recognize cancer, expand them into an army, and infuse them back in. For certain blood cancers, this is borderline miraculous - complete response rates that...

December 19, 2025

CDK4/6 Inhibition Provides Additional Efficacy in HER2+, HR+ Breast Cancer

CDK4/6 Inhibition Provides Additional Efficacy in HER2+, HR+ Breast Cancer

For years, oncologists operated under a tidy assumption: HER2-positive breast cancer and hormone receptor-positive breast cancer were essentially separate problems requiring separate playbooks. Target HER2 with trastuzumab and pertuzumab, treat HR+ disease with endocrine therapy and CDK4/6...